The Good Bug key facts
as of Oct 2026- Producer of water-soluble probiotics intended to improve overall core health, gut health and daily wellness.
- The Good Bug is valued at approximately $60.6M as of Oct 2026 (last reported valuation).
- It has raised $15.2M; the latest was Early Stage VC ($11.7M) in May 2025.
- Notable investors include Fireside Ventures, Alphatron Capital, Sharrp Ventures, Harsh Mariwala, SIG Venture Capital.
- Status: Privately Held (backing).
The Good Bug's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch The Good Bug: the Monday email on marks, rounds and moves
The Good Bug funding rounds
No funding rounds for The Good Bug are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs The Good Bug
5The Good Bug valuation
The Good Bug's last reported valuation was $60.6 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
The Good Bug investors
5 investors are on record for The Good Bug, including Fireside Ventures, Alphatron Capital, Sharrp Ventures and Harsh Mariwala.
About The Good Bug
Producer of water-soluble probiotics intended to improve overall core health, gut health and daily wellness. The company offers a wide range of products for weight management, bloating and gas, constipation, reproductive health, immunity and sleep, enabling users to have access to healthcare products.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Mumbai, India
- Founded
- 2021
- Employees
- 70
- Website
- thegoodbug.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.